Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment

Journal of Virology

Volumn 76, Issue 5, 2002, Pages 2340-2349

  Bantel Schaal, Ursula ^a   Hub, Birgit ^a   Kartenbeck, Juergen ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; APICAL MEMBRANE; ARTICLE; BINDING KINETICS; BIOACCUMULATION; CELL MEMBRANE; CELL VACUOLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOCYTOSIS; GENE THERAPY; GOLGI COMPLEX; HELA CELL; HELPER VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INCUBATION TIME; MICROVILLUS; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS PARTICLE; WESTERN BLOTTING; WILD TYPE;

BLOTTING, WESTERN; DEPENDOVIRUS; ENDOCYTOSIS; FLUORESCENT ANTIBODY TECHNIQUE; GOLGI APPARATUS; HELA CELLS; HUMANS; MICROSCOPY, ELECTRON; PARVOVIRIDAE INFECTIONS; VIRION;

EID: 0036174267     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.76.5.2340-2349.2002     Document Type: Article

References (67)

1. Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome
2. Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses
3. Characterization of the DNA of a defective parvovirus isolated from a genital site
4. Adeno-associated viruses inhibit SV40 DNA amplification and replication of herpes simplex virus in SV40-transformed hamster cells
5. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors
6. Infectious entry pathway for canine parvovirus
7. Repeated delivery of adeno-associated virus vectors to the rabbit airway
8. Parvoviridae: The viruses and their replication
9. Several log increase in therapeutic transgene delivery by distinct adenoassociated viral serotype vectors
10. Early events in the interaction of adenoviruses with HeLa cells. I. Penetration of type 5 and intracellular release of the DNA genome
11. Cloning and characterization of adeno-associated virus type 5
12. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles
13. Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle
14. From the cover: Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system
15. 2 activity is required for Golgi complex and trans Golgi network membrane tubulation
16. Intracellular trafficking of adeno-associated virus vectors: Routing to the late endosomal compartment and proteasome degradation
17. Dynamin is required for recombinant adeno-associated virus type 2 infection
18. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue
19. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
20. Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV)
21. Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus
22. An endocytosed TGN38 chimeric protein is delivered to the TGN after trafficking through the endocytic recycling compartment in CHO cells
23. Adeno-associated virus (AAV) serotypes as vectors for human gene therapy
24. Progress in adeno-associated virus type 2 vector production: Promises and prospects for clinical use
25. Trans-Golgi network sorting
26. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes
27. Adeno-associated virus type 2-mediated gene transfer: Altered endocytic processing enhances transduction efficiency in murine fibroblasts
28. Virus entry
29. On the entry of Semliki Forest virus into BKH-21 cells
30. Participation of dynamin in the biogenesis of cytoplasmic vesicles
31. Endosome to Golgi transport of ricin is independent of clathrin and of the Rab9- and Rab11-GTPases
32. Endocytosis of simian virus 40 into the endoplasmic reticulum
33. Impaired protein maturation of the conjugate export pump MRP2 as a consequence of a deletion mutation in Dubin-Johnson syndrome
34. Site-specific integration by adeno-associated virus
35. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
36. Molecular biology of adeno-associated viruses
37. Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of Shiga toxin B-fragment transport
38. Chimeric forms of furin and TGN38 are transported from the plasma membrane to the trans-Golgi network via distinct endosomal pathways
39. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors
40. Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults
41. The dynamin family of mechanoenzymes: Pinching in new places
42. AAV vectors: Is clinical success on the horizon?
43. Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3
44. Golgi apparatus, GERL, and lysosomes of neurons in rat dorsal root ganglia, studied by thick section and thin section cytochemistry
45. Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated clathrin-mediated endocytosis, followed by slower intracellular trafficking
46. Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: Human megakaryocytic leukaemia cells are non-permissive for AAV infection
47. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
48. Integrin αVβ5 is not involved in adenoassociated virus type 2 (AAV2) infection
49. The interaction of heparin sulfate and adeno-associated virus 2
50. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2
51. Targeted integration of adeno-associated virus (AAV) into human chromosome 19
52. Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by Rac1 and phosphatidylinositol-3 kinase activation
53. Characteristics and taxonomy of Parvoviridae
54. Delivery systems for gene therapy: Adeno-associate virus
55. Major histocompatibility complex class I molecules mediate association of SV40 with caveolae
56. 5 integrin: A co-receptor for adeno-associated virus type 2 infection
57. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
58. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome
59. Cell type-dependent variations in the subcellular distribution of alpha-mannosidase I and II
60. Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle
61. Intracellular route of canine parvovirus entry
62. Cytoplasmic trafficking of the canine parvovirus capsids and its role in infection and nuclear transport
63. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer
64. Intermediates of adeno-associated virus type 2 assembly: Identification of soluble complexes containing Rep and Cap proteins
65. Gene therapy vectors based on adeno-associated virus type 1
66. Development of novel cell surface CD34-targeted recombinant adeno-associated virus vectors for gene therapy
67. Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer